Long-term risks in hyperthyroid patients treated with radioiodine: is there anything new?
Lucignani
Giovanni
G
Institute of Radiological Sciences, University of Milan, Unit of Nuclear Medicine, Hospital San Paolo, Via Antonio di Rudinì, 8, 20142, Milan, Italy. giovanni.lucignani@unimi.it
D000328:Adult; D000368:Aged; D013956:Antithyroid Agents / Q000494:pharmacology; D003362:Cost-Benefit Analysis; D005260:Female; D006111:Graves Disease / Q000628:therapy; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications / Q000473:pathology* / Q000532:radiotherapy*; D007457:Iodine Radioisotopes / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D018803:Models, Economic; D012044:Regression Analysis; D013997:Time Factors; D016896:Treatment Outcome
D013956:Antithyroid Agents; D007457:Iodine Radioisotopes